BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 31083283)

  • 21. Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio.
    Katorcha E; Makarava N; Savtchenko R; Baskakov IV
    Sci Rep; 2015 Nov; 5():16912. PubMed ID: 26576925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation.
    Cordeiro Y; Machado F; Juliano L; Juliano MA; Brentani RR; Foguel D; Silva JL
    J Biol Chem; 2001 Dec; 276(52):49400-9. PubMed ID: 11604397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical significance of the region between Helix 1 and 2 for efficient dominant-negative inhibition by conversion-incompetent prion protein.
    Taguchi Y; Mistica AM; Kitamoto T; Schätzl HM
    PLoS Pathog; 2013; 9(6):e1003466. PubMed ID: 23825952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions.
    Saverioni D; Notari S; Capellari S; Poggiolini I; Giese A; Kretzschmar HA; Parchi P
    J Biol Chem; 2013 Sep; 288(39):27972-85. PubMed ID: 23897825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autocatalytic self-propagation of misfolded prion protein.
    Bieschke J; Weber P; Sarafoff N; Beekes M; Giese A; Kretzschmar H
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12207-11. PubMed ID: 15297610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allelic Interference in Prion Replication Is Modulated by the Convertibility of the Interfering PrP
    Espinosa JC; Andreoletti O; Marín-Moreno A; Lugan S; Aguilar-Calvo P; Cassard H; Lorenzo P; Douet JY; Villa-Díaz A; Aron N; Prieto I; Huor A; Torres JM
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discriminating between cellular and misfolded prion protein by using affinity to 9-aminoacridine compounds.
    Phuan PW; Zorn JA; Safar J; Giles K; Prusiner SB; Cohen FE; May BCH
    J Gen Virol; 2007 Apr; 88(Pt 4):1392-1401. PubMed ID: 17374787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential solubility of prions is associated in manifold phenotypes.
    Kuczius T; Karch H; Groschup MH
    Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
    Surewicz WK; Jones EM; Apetri AC
    Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolving views in prion glycosylation: functional and pathological implications.
    Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
    Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Region-Specific Sialylation Pattern of Prion Strains Provides Novel Insight into Prion Neurotropism.
    Makarava N; Chang JC; Baskakov IV
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prion protein misfolding.
    Kupfer L; Hinrichs W; Groschup MH
    Curr Mol Med; 2009 Sep; 9(7):826-35. PubMed ID: 19860662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aptamers against prion proteins and prions.
    Gilch S; Schätzl HM
    Cell Mol Life Sci; 2009 Aug; 66(15):2445-55. PubMed ID: 19396399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissociation of recombinant prion autocatalysis from infectivity.
    Noble GP; Supattapone S
    Prion; 2015; 9(6):405-11. PubMed ID: 26645356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prion protein aggregation and fibrillogenesis in vitro.
    Stöhr J
    Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of pH and aggregation in the human prion conversion into scrapie form: a study using molecular dynamics with excited normal modes.
    Lima AN; de Oliveira RJ; Braz ASK; de Souza Costa MG; Perahia D; Scott LPB
    Eur Biophys J; 2018 Jul; 47(5):583-590. PubMed ID: 29546436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcellular distribution of the prion protein in sickness and in health.
    Godsave SF; Peters PJ; Wille H
    Virus Res; 2015 Sep; 207():136-45. PubMed ID: 25683509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.